COMP <GO>
CVCO vs ECG // FREE CASH FLOW YIELD
Cavco Industries Inc. (NASDAQ) VS. Everus Construction Group Inc. (NYSE) • 15-METRIC TALLY: CVCO 8
— ECG 5
▲ FREE CASH FLOW YIELD LEADER: CVCO
LAST: $662.89 (+7.09%) • MKT CAP: $4.76B
fcf-yield
5.52%
LAST: $102.99 (+0.35%) • MKT CAP: $5.24B
fcf-yield
-0.21%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVCO VS. ECG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVCO | ECG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.50% | 12.10% | +11.40 | CVCO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.60% | 30.40% | -12.80 | ECG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.0x | 13.7x | +2.30 | ECG | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.52% | -0.21% | +5.73 | CVCO | /fcf-yield <GO> |
| Operating Margin | 10.20% | 7.10% | +3.10 | CVCO | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 5.40% | +3.10 | CVCO | /net-margins <GO> |
| Revenue Growth (YoY) | 11.40% | 31.50% | -20.10 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.31 | 6.47 | +3.84 | CVCO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | CVCO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.9 | 41.7 | +20.20 | CVCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 1.13 | -0.20 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.5x | 22.9x | -2.40 | CVCO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.76B | $5.24B | -$480.9M | ECG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVCO REV | ECG REV | CVCO GROSS % | ECG GROSS % | CVCO FCF | ECG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.24B | $3.75B | 23.5% | 12.1% | $232.1M | -$11.7M |
| FY 2024 | $2.02B | $2.85B | 23.1% | 11.9% | $157.1M | $35.1M |
| FY 2023 | $1.79B | $2.85B | — | — | $143.9M | $42.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVCO // BETA 0.93
ECG // BETA 1.13